Vikram Karnani
President and CEO at Collegium Pharmaceutical Inc.
Sits on 2 boards. Last updated September 28, 2026
Time on boards
- Boards served
- 2
- Current seats
- 2
- Board service
- 3 years
- Director since
- 2024
3 years of board service in total across 2 boards, counting each seat separately. Longest: Collegium Pharmaceutical Inc., 1 year.
Chief executive roles
Outstanding · grade A+
Out of 100, from shareholder return, dividends, growth and acquisitions.
Partial: only 35% of the scoring weight is on file.
- Revenue growth 20%
- 95
- Earnings growth 15%
- 88
17.4% a year in revenue
15.8% a year in earnings per share
35% of the scoring weight is on file. Figures cover December 2023 – December 2025.
Shareholder support
Support is votes for as a share of votes for and against (or withheld). Below 80% is a clear protest.
-
Collegium Pharmaceutical Inc. May 14, 202699.4%
-
Collegium Pharmaceutical Inc. May 15, 202599.6%
Insider trades
All notable trades →From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.
| Date | Company | Transaction | Shares | Price | Value |
|---|---|---|---|---|---|
| Feb 10, 2026 | Collegium Pharmaceutical Inc. | Grant or award | +79,264 | — | — |
| Feb 10, 2026 | Collegium Pharmaceutical Inc. | Grant or award | +32,531 | — | — |
| Feb 10, 2026 | Collegium Pharmaceutical Inc. | Shares withheld for tax | −11,296 | $46.75 | $528,088 |
| Nov 12, 2025 | Collegium Pharmaceutical Inc. | Shares withheld for tax | −8,983 | $47.35 | $425,345 |
| Nov 12, 2024 | Collegium Pharmaceutical Inc. | Grant or award | +105,972 | — | — |
Questions about Vikram Karnani
What boards is Vikram Karnani on?
Vikram Karnani sits on the boards of Collegium Pharmaceutical Inc. and Dyne Therapeutics Inc.
What company is Vikram Karnani the CEO of?
Vikram Karnani has been President and CEO of Collegium Pharmaceutical Inc. since November 2024.
How long has Vikram Karnani served on boards?
Our records show at least 3 years of board service across 2 boards, the earliest from 2024.
Reviews (0)
Sign in to write a review.
No reviews yet. Be the first to write one.